Advaxis Phase I Survival UpdateAdvaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has updated the survival information from its phase 1 trial of ADXS11-001 which assessed the safety of this agent in advanced, metastatic, progressive cervix cancer in women whose disease progressed subsequent to treatment with cytotoxic therapy...
Experts Concerned About Increase In HPV-Related Head And Neck CancersThe human papillomavirus increasingly is being identified as the cause of head and neck cancers, prompting some physicians to guess that the genesis of the cancers might be oral sex, the Raleigh News & Observer reports. David Brizel, an oncologist at Duke University who specializes in head and neck cancers, said, "A third of head and neck cancers we see nowadays are [related to] HPV...
Zetiq Reports CE Conformity For Its Cervical Cancer Diagnostic KitZetiq Technologies Ltd. ("Zetiq"), a subsidiary of Bio-Light Ltd. (TASE: BOLT), reports that it has fulfilled the essential requirements towards issuing a self declaration CE mark of conformity for its diagnostic product for identification of cervical cancer in cytological specimens...
Einstein Receives $4 Million To Test HPV MicrobicideThe National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard® against the human papillomavirus (HPV), which causes cervical cancer. The research will evaluate the efficacy of Carraguard®, a clear gel made from the seaweed derivative carrageenan in preventing new HPV infections in women...
Study Links Consistent Condom Use To Lower HPV Risk Among MenMen who consistently use condoms during sex are less likely to contract human papillomavirus than those who do not, according to a study published in the Journal of Infectious Diseases, Reuters reports. There are more than 100 strains of HPV, some of which can cause genital warts and lead to cervical cancer in women and anal and penile cancers in men...
Study Confirms Vaccine Could Prevent More Cases Of Cervical Cancers Than Previously ExpectedScientists at the Health Protection Agency (HPA), the University of Manchester and the Manchester Royal Infirmary have found that the cervical cancer vaccine could prevent more cases of the disease in England than previously thought, according to a study published in the British Journal of Cancer. This could potentially reduce the annual number of cases from around 3000 to less than 700...
A*STAR Scientists Score "Hat-Trick" Against CancerA*STAR scientists have made three separate groundbreaking discoveries in fight against cancer Scientists from Singapore's Agency of Science, Technology and Research (A*STAR) have made three successive breakthroughs in key areas of cancer research...
Aiming For An HPV Vaccine Cheap Enough For The Developing WorldVaccine manufacturers in India and other developing countries may be able to produce a lower-cost HPV vaccine in spite of the complicated array of patent protections on the technology, say researchers at the Duke Institute for Genome Sciences & Policy...